NHS Surrey Commissions Risk Stratification Tool from Docobo Ltd to Reduce Unplanned Admissions

Innovative technology developed by UK company Docobo Ltd, will support NHS Surrey in their initiatives to manage patients at home and reduce hospital admissions. NHS Surrey has commissioned Docobo Ltd to supply its new risk stratification tool, ArtemusICS™, that will enable GP practices in Surrey to better target their resources to deliver better outcomes for the 1.2 million people living in Surrey.

The tool takes patient data from both Primary and Secondary care and, through detailed analysis, will identify patients at risk of requiring future healthcare resources and who would likely benefit from a specific Long Term Condition intervention. The data is presented in a convenient 'dashboard' format so that information can be easily accessed via secure web access by authorised staff at GP practices. Data can be examined based on groups of patients, such as by practice or locality, or by clinical condition. Each patient is allocated a 'risk score' which predicts their risk of a hospital admission in the next year. Their GP can view this data and use it to direct their resources more effectively. This enables them toprovide more targeted personalised care and will help to identify and treat health problems earlier. Furthermore, the patients' risk scores can be monitored regularly to examine the effect effectiveness of treatments and interventions.

"We chose the ArtemusICS tool because it enables clinicians to target patients who would benefit from greater intervention, helping to reduce unplanned hospital admissions, which can be very distressing. Using this tool helps clinicians achieve the best possible outcomes for their patients and it also enables them to allocate their resources to best effect," said Christine Ratcliffe, Associate Director of IT Programmes, NHS Surrey. "The tool creates dashboards, which are easy to access, and give clinicians valuable insight into primary and seconday care data, helping them identify those most at risk and enabling them to tailor care to meet their needs. Docobo have worked with us to develop the tool to meet our requirements, and have delivered a quality product that is already making a real difference to GPs."

"Docobo is proud that our ArtemusICS system has been selected by NHS Surrey," said Adrian Flowerday, Managing Director, Docobo Ltd. "We are particularly delighted to have had the opportunity to work closely with Surrey to develop this tool to precisely fit their needs and we look forward to working with the GP practices in Surrey to roll this out."

About Docobo Ltd
Docobo Ltd is a UK medical device company that supplies eHealth solutions to enable Community Care and improve the quality of life of patients, carers and clinicians. More than 40 PCTs and Trusts in the UK and several international healthcare organisations are currently using doc@HOME Telehealth to support their patients.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, DĂĽsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...